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Abstract 
South Africa has the greatest number of people living with HIV in the world but the direct impact of this on the public health 
system has not been directly measured. Using data from the Chris Hani Baragwanath Hospital, the largest hospital in the 
Southern Hemisphere, collected between January 2006 and December 2009, we demonstrate directly the scale of the impact of 
HIV on mortality in health services in the pubic sector in South Africa. During the period under investigation 14,431 people 
died in the hospital’s medical wards, an average of 11 deaths each day. Of those that died 64% of men and 82% of women 
were HIV positive. Between the ages of 30 and 40, 94% of men and 96% of women of those that died were HIV-positive. 
These data not only reflect the extraordinary mortality directly attributable to the epidemic of HIV but also the massive burden 
placed on the health services at a time when triple combination therapy was available and these HIV-related deaths could have 
been averted. 
 
Introduction 
South Africa has, and continues to have, the greatest 
number of people infected with HIV in the world. Among 
adults aged 15 years or more, the annual incidence of HIV 
peaked at 2.5% in 1998, the prevalence of HIV reached 
16% in 2006 and has not declined significantly since then, 
and the annual mortality peaked at 1.3% in 2007. The 
availability of ART in the public sector began in earnest in 
2003 but by 2009 only 2.5% of adults were on ART, or 
about 16% of those infected with HIV. Since then the 
provision of ART has been scaled up rapidly and in 2015 
about 10% of all adults are on ART or about 63% of all 
those living with HIV.1 
 For this study one of us (AB) collected detailed 
mortality data for everyone that died in the Chris Hani 
Baragwanath Hospital (CHBH) Medical wards between 
2006 and 2009, during which time the incidence and the 
mortality reached their peak values and the rollout of ART 
in the public sector began. In 1996 triple combination 
therapy was already widely used in many countries and for 
many people infected with HIV, and/or those taking triple 
combination therapy, the excess mortality, was moderate 
and comparable with patients having other chronic 
conditions.2 The data collected in this study therefore cover 
a critical period in the history of HIV in South Africa when 
the epidemic had reached its apogee but when effective 
treatment was widely available. 
 The impact of HIV not only on he lives and deaths of 
individual people but also the burden that it placed on the 
health services in the period from 2006 to 2009 are 
therefore of particular importance. In this paper we focus 
on the proportion of those that died who had been tested 
positive for HIV as a function of their age and gender. We 
will report the relationship between HIV status and 
different underlying causes of death in a later publication. 
Methods  
In order to enable monitoring of deaths at CHBAH a data 
sheet was developed in 2006 to serve as a paper based 
mortality record. The data form was completed by a 
medical consultant at the time of signing the patients’ death 
certificate. Cause of death was ascertained by the medical 
consultant by reviewing the patient file and the cause of 
death reported by the medical consultant may not be the 
same as that reported on the death certificate; because of 
the stigma surrounding HIV and HIV-related diseases HIV 
is not always recorded on the death certificate which is 
made available to patients families at CHBH. HIV status 
was reported as known positive, known negative, not 
known or clinically suspected because of AIDS-defining 
illness. If the HIV-status was not available in the patient 
records a search of the hospital laboratory records was done 
and the data sheet updated by an investigator (AB). 
 The CD4 cell count reported is the last available result 
on the hospital laboratory system, the vast majority having 
been taken during final admission. Antiretroviral therapy 
status was determined from patient records. 
 The data was captured into Microsoft Excel 2007 
(Microsoft, Redmond, WA). Cause of death was coded 
using the Tenth International Classification of Diseases 
codes (ICD-10), by a person trained in ICD-10 coding. 
When queries arose a consultant (AB) assisted in assigning 
the code. Primary cause and possible secondary causes of 
death were coded but only the primary cause of death was 
used for this analysis. 
 The data for HIV-positive and HIV-negative men and 
women by age were fitted to skew-normal distributions so 
that N(a), the number of people of age a, for each gender is 
given by 
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where N is the normalization parameter, μ is the location 
parameter, σ is the scale parameter, and α determines the 
skewness of the distribution. 
 For those whose HIV status is known we fitted Equation 
1 separately for each gender and for HIV-positive and HIV-
negative people. For those whose HIV status was not 
known we fitted a curve of the form 
 ( ) ( ) ( )N a N a N aπ ν+ −= +  2 
where we used the estimated location, scale and shape 
parameters for positive and negative men and women and 
varied the normalization parameters π and ν to fit the 
estimated proportion of men and women, of unknown 
status, that are HIV-positive or HIV-negative. 
Results 
Figure 1 shows the age distribution for HIV-positive men 
and women; the parameters from the fits are given in Table 
1. As expected the peak age at death in HIV negative 
women (pink line) is 75 years while in HIV-negative men 
(light blue line) it is 65 years. However, the peak age at 
death in HIV-positive women is 33 years while in HIV-
positive men it is 38 years. Not only does HIV massively 
increase mortality, with 82% of women and 64% of men 
being HIV-positive but the modal age of death in those that 
were HIV-positive is shifted down by 42 years in women 
and 27 years in men. 
 
 
 
 
 
 
 
 
 
 
Figure 1. The number of men and women that died as a function 
of age. Red: HIV-positive women; Pink: HIV-negative women; 
Blue: HIV-positive men; Light blue: HIV-negative men; Black 
HIV-unknown men; Gray: HIV-unknown women. 
 The parameters for the fits are given in Table 1. For 
both men and women the distribution of those that are HIV-
positive is shifted to younger ages and is much narrower. 
However, the age-distributions are skew to the left in those 
that are HIV-negative and skew to the right in those that are 
HIV-positive.  
 Using the fitted curves shown in Figure 1 and the 
parameters given in Table 1 we fitted the data for those 
whose HIV-status was not known and estimate the 
proportion of men and women who were infected with HIV 
among those whose status was unknown. This suggests that 
among those whose status was unknown only 6.7% of men 
and 6.8% of women were HIV-positive so that those of 
unknown status were overwhelmingly HIV-negative.  
Table 1. Parameters from the fits in Figure 1 for men 
(M) and women (W) who are HIV-positive (+) or 
negative (−). N is the normalization factor, μ the 
location parameter, σ the scale parameter and α the 
shape parameter as given in Equation 1. 
 M− M+ W− W+ 
N  4315 1415 4834 1571 
μ 29.9 77.9 24.9 85.7 
σ 14.8 27.0 16.4 32.2 
α 2.63 −2.67 3.46 −4.85 
 
 It is also instructive to plot the proportion of men and 
women who were HIV-positive as a function of age and 
this is shown in Figure 2. Between the ages of 21 and 43 
years for women and 26 and 43 years for men, more than 
90% of the deaths that occurred in Baragwanath were 
among those infected with HIV.  
 
 
 
 
 
 
 
 
 
 
Figure 2. The proportion of men (blue dots and line) and women 
(red dots and line) who died and were HIV-positive as a function 
of age. 
Discussion 
The epidemic of HIV has not only led to the deaths of 
several million people in South Africa but the mortality has 
been particularly severe among women aged 16 years to 60 
years and among men aged 20 years to 60 years. Apart 
from the personal tragedies associated with each death, 
killing working aged adults will have had a very substantial 
impact on the economy of the country. Furthermore, in a 
country struggling to cope with a dysfunctional public 
health system the effect of HIV has been to increase the 
number of people dying in the major pubic hospital by four 
times. The recent recommendation by the World Health 
Organization to start people on ART as soon as possible 
after infection3 should dramatically reduce not only AIDS 
related deaths but also the burden on the pubic health 
system. 
Conclusion 
The tragedy is that South Africa, like many other countries, 
failed to provide triple combination therapy much earlier in 
the epidemic as this would have saved the lives of millions 
of young adults, minimized the economic impact of HIV, 
and very substantially reduced the burden on the health 
system. While it is true that in 2006 the cost of a course of 
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ART was about US$730 per year it has now fallen to about 
US$100 per year4 so that even maintaining 6 million people 
onto ART would only cost about US$600 million per year 
for the drugs or about 0.1% of the Gross Domestic 
Product.5 Now that the WHO has embraced immediate 
treatment with ART for all those infected with HIV it is 
imperative that this is done to save lives, save money and 
make it possible to greatly reduce the burden on the health 
system thereby providing better health for all South 
Africans. 
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